Here's Why You Should Retain OPKO Health Stock in Your Portfolio [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
The optimism surrounding the stock is backed by RAYALDEE's performance and strategic partnerships. However, stiff competition and overdependence on RAYALDEE are concerns. Shares of this Zacks Rank #3 (Hold) company have lost 1.3% year to date against the industry 's 9.8% growth. The S&P 500 has gained 21% in the said time frame. This renowned multinational biopharmaceutical and diagnostics company has a market capitalization of $1.03 billion. It projects 44.4% growth for 2025 and expects to maintain its strong performance. In the trailing four quarters, OPKO Health surpassed earnings estimates once, matched estimates once and missed on two occasions, the average beat being 8.34%. Image Source: Zacks Investment Research Factors Favoring OPK Stock Potential of RAYALDEE : It has been a key driver of OPKO Health's pharmaceutical performance, leading the U.S. renal market for the past two years as the only FDA-approved therapy for secondary hyperparathyroidism (SHPT) in adults wi
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover [Yahoo! Finance]Yahoo! Finance
- Eileen Fisher zeroes in on the millennials and Gen Z shoppers who love ‘slow fashion' and ‘quiet luxury' [Fortune]Fortune
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary [Yahoo! Finance]Yahoo! Finance
- Phillip Frost Buys Handful Of Shares In OPKO Health [Yahoo! Finance]Yahoo! Finance
OPK
Earnings
- 11/7/24 - Beat
OPK
Sec Filings
- 11/22/24 - Form 4
- 11/20/24 - Form 4/A
- 11/15/24 - Form SC
- OPK's page on the SEC website